DE69532921D1 - Angesäuertes nitrit zur verwendung als antimikrobielles mittel - Google Patents

Angesäuertes nitrit zur verwendung als antimikrobielles mittel

Info

Publication number
DE69532921D1
DE69532921D1 DE69532921T DE69532921T DE69532921D1 DE 69532921 D1 DE69532921 D1 DE 69532921D1 DE 69532921 T DE69532921 T DE 69532921T DE 69532921 T DE69532921 T DE 69532921T DE 69532921 D1 DE69532921 D1 DE 69532921D1
Authority
DE
Germany
Prior art keywords
antimicrobial agent
acidified nitrite
agent
dosage form
applications
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69532921T
Other languages
English (en)
Other versions
DE69532921T2 (de
Inventor
Nigel Benjamin
Hamish Dougall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Aberdeen
Original Assignee
University of Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9403284A external-priority patent/GB9403284D0/en
Priority claimed from GB9404365A external-priority patent/GB9404365D0/en
Application filed by University of Aberdeen filed Critical University of Aberdeen
Application granted granted Critical
Publication of DE69532921D1 publication Critical patent/DE69532921D1/de
Publication of DE69532921T2 publication Critical patent/DE69532921T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69532921T 1994-02-21 1995-02-17 Angesäuertes nitrit zur verwendung als antimikrobielles mittel Expired - Lifetime DE69532921T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9403284A GB9403284D0 (en) 1994-02-21 1994-02-21 Acidified nitrite as antimicrobial agent
GB9403284 1994-02-21
GB9404365 1994-03-07
GB9404365A GB9404365D0 (en) 1994-03-07 1994-03-07 Acidified nitrate as antimicrobial agent
PCT/GB1995/000338 WO1995022335A1 (en) 1994-02-21 1995-02-17 Acidified nitrite as an antimicrobial agent

Publications (2)

Publication Number Publication Date
DE69532921D1 true DE69532921D1 (de) 2004-05-27
DE69532921T2 DE69532921T2 (de) 2005-04-14

Family

ID=26304368

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69532921T Expired - Lifetime DE69532921T2 (de) 1994-02-21 1995-02-17 Angesäuertes nitrit zur verwendung als antimikrobielles mittel

Country Status (17)

Country Link
EP (1) EP0746327B1 (de)
JP (1) JP3875262B2 (de)
KR (1) KR100385297B1 (de)
CN (1) CN1145491C (de)
AT (1) ATE264685T1 (de)
AU (1) AU693851B2 (de)
BR (1) BR9507099A (de)
CA (1) CA2183549C (de)
CZ (1) CZ286286B6 (de)
DE (1) DE69532921T2 (de)
DK (1) DK0746327T3 (de)
ES (1) ES2218541T3 (de)
FI (1) FI114852B (de)
NO (1) NO311494B1 (de)
PL (1) PL180769B1 (de)
PT (1) PT746327E (de)
WO (1) WO1995022335A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9804469D0 (en) * 1998-03-02 1998-04-29 Univ Aberdeen Antiviral composition
US6709681B2 (en) 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
SE9700617D0 (sv) * 1997-02-21 1997-02-21 Kjell Alving New composition
US6682732B1 (en) 1998-08-28 2004-01-27 The University Of Bath Treatment of lesions
GB9905425D0 (en) * 1999-03-09 1999-05-05 Queen Mary & Westfield College Pharmaceutical composition
GB0021317D0 (en) * 2000-08-30 2000-10-18 Queen Mary & Westfield College Transdermal pharmaceutical delivery composition
GB0022084D0 (en) * 2000-09-08 2000-10-25 Univ Aberdeen Treatment of multiply antibiotic-resistant organisms
US6432077B1 (en) * 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
GB0119011D0 (en) * 2001-08-03 2001-09-26 Univ Aberdeen Treatment of nail infections
DK1455888T3 (da) 2001-08-29 2009-08-24 Pharmakodex Ltd Topisk indgivelsesindretning
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
ES2294543T3 (es) 2003-07-09 2008-04-01 The Government Of The United States Of America, As Represented By The Secretary, Department Of Heal Uso de sales de nitrilo para el tratamiento de afecciones cardiovasculares.
JP2008529626A (ja) * 2005-02-11 2008-08-07 ノーラブズ エービー 皮膚真菌症、特に爪真菌症を治療するデバイスおよびその製造方法
US8557300B2 (en) 2005-05-19 2013-10-15 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
EP3556401A1 (de) 2005-05-27 2019-10-23 The University of North Carolina at Chapel Hill Stickoxidfreisetzende partikel für stickoxidtherapeutika und biomedizinische anwendungen
GB0604319D0 (en) * 2006-03-03 2006-04-12 Optinose As Nasal delivery
GB0607402D0 (en) * 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
GB0618711D0 (en) * 2006-09-22 2006-11-01 Univ Exeter Agricultural treatment
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
BR112012003804B1 (pt) 2009-08-21 2019-02-19 Novan, Inc. Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118829A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same
RU2016106303A (ru) * 2013-10-31 2017-12-05 Ориджин, Инк. Способы применения оксида азота (ii) в состоянии плазмы для лечения медицинских состояний и заболеваний
CA2950314A1 (en) * 2014-06-13 2015-12-17 Origin, Inc. Veterinary methods for using nitric oxide in a plasma state to treat medical conditions and diseases in animals
KR20170117380A (ko) * 2014-12-05 2017-10-23 캔 테크놀로지스 인코포레이티드 동물 사료 보충제 및 방법
KR20200027951A (ko) 2017-06-23 2020-03-13 캔 테크놀로지스 인코포레이티드 육류 품질 개선 방법
CA3142101A1 (en) 2019-06-04 2020-12-10 Thirty Holdings Limited Methods and compositions for generating nitric oxide and uses thereof
GB2599818B (en) 2019-06-04 2024-01-31 Thirty Respiratory Ltd Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
JP2023526584A (ja) 2020-04-23 2023-06-22 サーティー レスピラトリー リミテッド Ｓａｒｓ－ｃｏｖ及びｓａｒｓ－ｃｏｖ－２の治療に使用するための一酸化窒素または一酸化窒素放出組成物
JP2023526583A (ja) 2020-04-23 2023-06-22 サーティー レスピラトリー リミテッド 結核を治療及び抑制するための方法及び組成物
GB202101543D0 (en) 2021-02-04 2021-03-24 Thirty Respiratory Ltd Vaping e-liquid composition and the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191750A (en) * 1976-03-08 1980-03-04 Milton Hodosh Method for treating canker sores
JPS5985278A (ja) * 1982-11-05 1984-05-17 Agency Of Ind Science & Technol 食品の保存方法及び保存材
JPH0622540B2 (ja) * 1985-12-18 1994-03-30 株式会社祥光化学研究所 消臭抗菌能を有する構造物

Also Published As

Publication number Publication date
FI963232A (fi) 1996-09-12
JP3875262B2 (ja) 2007-01-31
PL316033A1 (en) 1996-12-23
DK0746327T3 (da) 2004-05-10
PT746327E (pt) 2004-06-30
CA2183549C (en) 2006-09-12
EP0746327B1 (de) 2004-04-21
NO311494B1 (no) 2001-12-03
ATE264685T1 (de) 2004-05-15
CZ245696A3 (en) 1997-01-15
CN1145491C (zh) 2004-04-14
CZ286286B6 (cs) 2000-03-15
CN1144484A (zh) 1997-03-05
FI963232A0 (fi) 1996-08-16
CA2183549A1 (en) 1995-08-24
ES2218541T3 (es) 2004-11-16
FI114852B (fi) 2005-01-14
AU1669995A (en) 1995-09-04
NO963446D0 (no) 1996-08-19
PL180769B1 (pl) 2001-04-30
AU693851B2 (en) 1998-07-09
KR100385297B1 (ko) 2003-10-10
NO963446L (no) 1996-10-21
WO1995022335A1 (en) 1995-08-24
DE69532921T2 (de) 2005-04-14
BR9507099A (pt) 1997-09-16
JPH09508921A (ja) 1997-09-09
EP0746327A1 (de) 1996-12-11

Similar Documents

Publication Publication Date Title
ATE264685T1 (de) Angesäuertes nitrit zur verwendung als antimikrobielles mittel
WO1992019104A3 (en) Fatty acid based compositions for the control of established plant infections
WO2000034265A3 (en) Quinoline-indole antimicrobial agents
MXPA02012326A (es) Peptidos quimicamente modificados, composiciones y metodos para su produccion y uso.
AU4718496A (en) Use of aerogels in agriculture
PL352318A1 (en) Fish serine proteinases, and pharmaceutical and cosmetic use of same
AU3620095A (en) Use of starch for transdermal applications
PL344049A1 (en) Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
DK0964687T3 (da) Farmaceutiske sammensætninger med antimikrobiel aktivitet
AU4651700A (en) Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases
WO1999067238A3 (en) Tetrahydroquinoline-indole derivatives antimicrobial agents, their uses and compositions containing them
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
WO2003009859A1 (fr) Immunotherapie pour humains
ATE260097T1 (de) Hopfensäuren zur hemmung von staphylococcus aureus
BG105120A (en) Chemotaxis-inhibiting protein of staphylococcus (chips) and its use
MX9603535A (es) Nitrito acido como un agente antimicrobiano.
BG104259A (en) Derivatives of 4-cyano-4-deformylsordaricin
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ES8707955A1 (es) Un procedimiento para la preparacion pirazolidinonas biciclicas'
GEP20033144B (en) Hygromycin A Derivatives as Antibacterial Agents
MXPA05013760A (es) Composicion y procedimiento de tratamiento del platanero y del bananero.
MX9603754A (es) Compuestos, de amplio espectro, activos contra microbios.
MX9708385A (es) Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition